Literature DB >> 16084691

A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail.

Alastair W Poole1, Matthew L Jones.   

Abstract

Protein tyrosine phosphorylation is a ubiquitous signalling mechanism and is regulated by a balance between the action of kinases and phosphatases. The SH2 domain-containing phosphatases SHP-1 and SHP-2 are the best studied of the classical non-receptor tyrosine phosphatases, but it is intriguing that despite their close sequence and structural homology these two phosphatases play quite different cellular roles. In particular, whereas SHP-1 plays a largely negative signalling role suppressing cellular activation, SHP-2 plays a largely positive signalling role. Major sequence differences between the two molecules are apparent in the approximately 100 amino acid residues at the extreme C-terminus of the proteins, beyond the phosphatase catalytic domain. Here we review how the differences in the tails of these proteins may regulate their activities and explain some of their functional differences.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16084691     DOI: 10.1016/j.cellsig.2005.05.016

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  65 in total

1.  PKC-α contributes to high NaCl-induced activation of NFAT5 (TonEBP/OREBP) through MAPK ERK1/2.

Authors:  Hong Wang; Joan D Ferraris; Janet D Klein; Jeff M Sands; Maurice B Burg; Xiaoming Zhou
Journal:  Am J Physiol Renal Physiol       Date:  2014-11-12

2.  Activation or tolerance of natural killer cells is modulated by ligand quality in a nonmonotonic manner.

Authors:  Jayajit Das
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

Review 3.  The role of Src homology 2 containing protein tyrosine phosphatase 2 in vascular smooth muscle cell migration and proliferation.

Authors:  Machender R Kandadi; Matthew S Stratton; Jun Ren
Journal:  Acta Pharmacol Sin       Date:  2010-09-27       Impact factor: 6.150

4.  Importance of protein-tyrosine phosphatase-alpha catalytic domains for interactions with SHP-2 and interleukin-1-induced matrix metalloproteinase-3 expression.

Authors:  Qin Wang; Dhaarmini Rajshankar; Carol Laschinger; Ilana Talior-Volodarsky; Yongqiang Wang; Gregory P Downey; Christopher A McCulloch
Journal:  J Biol Chem       Date:  2010-05-14       Impact factor: 5.157

5.  Increased expression of tyrosine phosphatase SHP-2 in Helicobacter pylori-infected gastric cancer.

Authors:  Jing Jiang; Mei-Shan Jin; Fei Kong; Yin-Ping Wang; Zhi-Fang Jia; Dong-Hui Cao; Hong-Xi Ma; Jian Suo; Xue-Yuan Cao
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

6.  Poliovirus entry into human brain microvascular cells requires receptor-induced activation of SHP-2.

Authors:  Carolyn B Coyne; Kwang S Kim; Jeffrey M Bergelson
Journal:  EMBO J       Date:  2007-08-23       Impact factor: 11.598

7.  SHP-1 Acts as a Key Regulator of Alloresponses by Modulating LFA-1-Mediated Adhesion in Primary Murine T Cells.

Authors:  Martin G Sauer; Jessica Herbst; Ulf Diekmann; Christopher E Rudd; Christian Kardinal
Journal:  Mol Cell Biol       Date:  2016-11-28       Impact factor: 4.272

8.  The phosphatase Shp2 is required for signaling by the Kaposi's sarcoma-associated herpesvirus viral GPCR in primary endothelial cells.

Authors:  Thomas Bakken; Meilan He; Mark L Cannon
Journal:  Virology       Date:  2009-12-09       Impact factor: 3.616

Review 9.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

10.  Role of tyrosine phosphatase SHP-1 in the mechanism of endorepellin angiostatic activity.

Authors:  Alexander Nyström; Zabeena P Shaik; Donald Gullberg; Thomas Krieg; Beate Eckes; Roy Zent; Ambra Pozzi; Renato V Iozzo
Journal:  Blood       Date:  2009-09-29       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.